Amy E Clarke|Luba Sobolevsky - JoVE Visualize

Showing results (1-10 of 4) with videos related to

Pageof 1

Sort By:

Home Healthcare Now|February 28, 2025

Immunoglobulin Therapy and Standards of PracticeAmy E Clarke, Luba Sobolevsky

Mayo Clinic Proceedings. Innovations, Quality & Outcomes|January 29, 2024

A Practical Guide to Identify Patients With Multifocal Motor Neuropathy, a Treatable Immune-Mediated NeuropathyJeffrey A Allen, Amy E Clarke, Thomas Harbo

Communications Medicine|December 20, 2023

Large-scale deep learning analysis to identify adult patients at risk for combined and common variable immunodeficienciesGiorgos Papanastasiou, Guang Yang, Dimitris I Fotiadis, et al.

Journal of Clinical Immunology|March 23, 2011

Efficacy, safety, and pharmacokinetics of a 10% liquid immune globulin preparation (GAMMAGARD LIQUID, 10%) administered subcutaneously in subjects with primary immunodeficiency diseaseRichard L Wasserman, Isaac Melamed, Lisa Kobrynski, et al.

Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:

Pageof 1

Home Healthcare Now|February 28, 2025

Immunoglobulin Therapy and Standards of PracticeAmy E Clarke, Luba Sobolevsky

Mayo Clinic Proceedings. Innovations, Quality & Outcomes|January 29, 2024

A Practical Guide to Identify Patients With Multifocal Motor Neuropathy, a Treatable Immune-Mediated NeuropathyJeffrey A Allen, Amy E Clarke, Thomas Harbo

Communications Medicine|December 20, 2023

Large-scale deep learning analysis to identify adult patients at risk for combined and common variable immunodeficienciesGiorgos Papanastasiou, Guang Yang, Dimitris I Fotiadis, et al.

Journal of Clinical Immunology|March 23, 2011

Efficacy, safety, and pharmacokinetics of a 10% liquid immune globulin preparation (GAMMAGARD LIQUID, 10%) administered subcutaneously in subjects with primary immunodeficiency diseaseRichard L Wasserman, Isaac Melamed, Lisa Kobrynski, et al.

Pageof 1